Novartis Reveals New Collaborators to Beacon of Hope Initiative
Expansion aims to continue to create programs that address health and education inequities.
With the goal of diversifying clinical trials, breaking down economic and educational barriers, and creating greater trust across research and development, Novartis announced on July 12, 2023 the inclusion of six new organizations to its Beacon of Hope Initiative. The company selected the new organizations to provide tools and expertise to enable the Historically Black Medical School Centers of Excellence to accelerate progress on increasing diversity, equity, and inclusion in clinical trials and support new research into healthcare disparities.
Those organizations include:
- Advarra
- Virb
- BeeKeeperAI
- Amgen
- Alnylam
- Global Black Economic Forum (GBEF)
According to the Novartis press release,1 Advarra will support clinical trial-site management, BeeKeeperAI is providing a privacy-preserving collaboration platform that enables protected algorithms to compute on real-world data, and Virb will help with the sourcing and training of clinical trial coordinators and research study staff. Amgen and Alnylam will run clinical trials through the Centers of Excellence. Alnylam, specifically, also intends to offer an opportunity for under-represented students who want to pursue careers in drug development to attend a summer fellowship program.
Lastly, GBEF joins the Beacon of Hope to empower the next generation of diverse leaders in STEM while working to address economic disparities. They will offer career training and leadership development programs to students enrolled in Novartis and Thurgood Marshall College Fund scholarship and mentorship programs.
"Our relentless commitment to the success of Beacon of Hope led us to undertake a comprehensive assessment of where we have made important progress and where we still have gaps to fulfilling the mission of the program,” said Linda Armstrong, US Novartis Foundation President, head of Novartis US corporate responsibility, in the company press release. “We actively sought out collaborations with organizations that both possess the expertise necessary to bridge these gaps—particularly on the technology front—and that share our unwavering mission to tackle the fundamental factors that contribute to health and education disparities."
Reference
- Novartis, “Novartis Strengthens Commitment to Beacon of Hope Initiative, Engages New Collaborators to Support Clinical Trial Diversity, Break Down Economic and Education Barriers,” press release, July 12, 2023. https://www.novartis.com/us-en/news/media-releases/novartis-strengthens-commitment-beacon-hope-initiative-engages-new-collaborators-support-clinical-trial-diversity-break-down-economic-and-education-barriers
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
A Guide to Patient Engagement & Recruitment Solutions
March 18th 2025Clinical trials have become increasingly complex over the past decades, making participant recruitment more challenging than ever. This guide explores common recruitment obstacles and offers strategies to overcome them using a patient engagement and recruitment solution.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Bridging the Gap: How Chiesi Used External Collaboration to Get Closer to Patients
March 18th 2025Chiesi partnered with Citeline to enhance clinical trial awareness and patient engagement through its FREUD initiative by launching a Trial Portfolio Website, activating 150+ sites, and generating 600+ qualified referrals—learn more about how Citeline helped improve study discoverability, streamline recruitment, and strengthen Chiesi’s presence in key therapeutic areas.
Citeline Patient Engagement & Recruitment Solutions
March 18th 2025Watch Citeline’s 15-minute presentation from Clinical Leader’s Patient Engagement & Recruitment Solutions Expo, where VP Matt Holms explores Direct-to-Data (DTD) patient recruitment. This session takes a deep dive into how complex algorithms, tokenized data, and large data assets can optimize enrollment, highlighting the importance of early strategic recruitment planning and breaking down the unique benefits and real-world applications of DTD.
